Showing 3441-3450 of 21434 results for "".
- Cumulative Epinephrine Doses Over 3 mg During ECPR Increase Risk of Unfavorable Neurologic Outcomes at Dischargehttps://reachmd.com/news/cumulative-epinephrine-doses-over-3-mg-during-ecpr-increase-risk-of-unfavorable-neurologic-outcomes-at-discharge/2467385/Photo Credit: Eugene Nekrasov The following is a summary of “Cumulative epinephrine dose during cardiac arrest and neurologic outcome after extracorporeal cardiopulmonary resuscitation,” published in the June 2024 issue of Emergency Medicine
- Even Mild SARS-CoV-2 Infections Have a Long-Term Impact on the Immune System, Finds Studyhttps://reachmd.com/news/even-mild-sars-cov-2-infections-have-a-long-term-impact-on-the-immune-system-finds-study/2467367/Impact of primary SARS-CoV-2 infection on leukocyte subpopulations as determined after 10 weeks and 10 months. Shown are absolute values of the indicated leukocyte populations in peripher
- Rilzabrutinib Improves Asthma Symptoms in the First 2 Weeks of Treatment, Study Findshttps://reachmd.com/news/rilzabrutinib-improves-asthma-symptoms-in-the-first-2-weeks-of-treatment-study-finds/2467354/Patients experienced rapid improvement in asthma symptoms, even with withdrawal from inhaled corticosteroids (ICS) and long-acting β-agonists (LABA), Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, said in an interview.The findings from the doub
- Association Between Mortality Risk and Iron Metabolic Biomarkers in the General Populationhttps://reachmd.com/news/association-between-mortality-risk-and-iron-metabolic-biomarkers-in-the-general-population/2467374/The following is a summary of “Iron Metabolic Biomarkers and the Mortality Risk in the General Population: A Nationwide Population-Based Cohort Study,” published in the June 2024 issue of Endocrinology by Sun, et al. Iron
- New Intervention Boosts Sunscreen Usehttps://reachmd.com/news/new-intervention-boosts-sunscreen-use/2467338/New research puts forth a potential approach for promoting sunscreen use to combat the persistent prevalence of skin cancer. "While the risks of not wearing sunscreen are well-documented, there are no effective interventions to promote sunscreen use across populations, and existing interv
- Deep and Durable Responses: Ide-Cel CAR T Shows Promise for High-Risk Multiple Myeloma Relapsehttps://reachmd.com/news/deep-and-durable-responses-ide-cel-car-t-shows-promise-for-high-risk-multiple-myeloma-relapse/2467348/Bone marrow aspirate cytology of multiple myeloma: ©David A Litman - stock.adobe.comTreatment with the chimeric antigen receptor (CAR) T-cell therapy idecabtagene vicleucel (ide-cel; Abecma) demonstrated frequeny, durable responses when
- Frontiers | Microfibrillar-Associated Protein 4 Interaction with Inflammation and Clinical Characteristics in Neuropsychiatric Systemic Lupus Erythematosushttps://reachmd.com/news/frontiers-microfibrillar-associated-protein-4-interaction-with-inflammation-and-clinical-characteristics-in-neuropsychiatric-systemic-lupus-erythematosus/2467334/1 Introduction Systemic lupus erythematosus (SLE) is an autoimmune, systemic inflammatory disorder with a heterogeneous clinical presentation (1
- Investigational Therapy NKX019 for Lupus Nephritis Treatment Begins Screening Trial Participantshttps://reachmd.com/news/investigational-therapy-nkx019-for-lupus-nephritis-treatment-begins-screening-trial-participants/2467335/A multi-center clinical trial of investigational therapy, NKX019, for the treatment of lupus nephritis (LN, l
- Food Insecurity and Nutrition Insecurity Challenge LA Countyhttps://reachmd.com/news/food-insecurity-and-nutrition-insecurity-challenge-la-county/2467314/While food insecurity has long been the focus of local and national policymakers and researchers, nutrition insecurity has largely been overlooked. A new study b
- Semaglutide Linked to Increased Risk of Severe Eye Condition NAION in New Studyhttps://reachmd.com/news/semaglutide-linked-to-increased-risk-of-severe-eye-condition-naion-in-new-study/2467302/A recent study published in the journal JAMA Ophthalmology evaluated associations between semaglutide and the risk of non-arteritic anterior ischemic o